Mind-mapping for lung cancer: towards a personalized therapeutics approach - Test2 - elhamkhani - TriplyDB

Mind-mapping for lung cancer: towards a personalized therapeutics approach

Mind-mapping for lung cancer: towards a personalized therapeutics approach

http://www.wikidata.org/entity/Q34796086

about

Advances of molecular subtype and targeted therapy of lung cancer A novel classification of lung cancer into molecular subtypes U.S. Food and Drug Administration approval summary: Erlotinib for the first-line treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations.Gene expression profiling analysis of lung adenocarcinoma Developing a mind map-based life review program to improve psychological well-being of cancer patients: a feasibility study.[Joint serum tumor markers serve as survival predictive model of erlotinib in the treatment of recurrent non-small cell lung cancer].[Driver genes and its clinical significance in non-small cell lung cancer].Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis

P2860

Q27030813-95E5D791-4E59-42F2-8DED-1F895153C90F Q28731874-159CF7F3-9EA2-4641-8C98-F3CC9090B60D Q33829794-DAD4E08C-A7EF-4182-8179-3F4D7AEF52E7 Q36607728-ACEB2161-13C4-4D6F-A3EB-FDC38B1D22C9 Q39149020-FE655BD7-162F-435E-AD66-895EDF4BCFDB Q55439438-E3FDCCAA-9ED4-42D6-A209-13E65E6AAD2F Q55464378-F170304A-6129-4F2E-A734-E64E8EA627A0 Q58615775-88DE6E6D-2E63-4BA5-825B-942BC9DE4C95

P2860

Mind-mapping for lung cancer: towards a personalized therapeutics approach

http://www.wikidata.org/entity/Q34796086

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@ast

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@en

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@nl

type

label

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@ast

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@en

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@nl

prefLabel

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@ast

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@en

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@nl

P1433

Q34796086-A525C7DB-729B-42ED-AB9E-13C845F6F745

P1476

Q34796086-D9F67BA1-A286-44AE-BF19-F43921C6B2F1

P2093

Q34796086-00EDC7D8-AA5B-4767-AB4A-7B49290CBD4C

Q34796086-06EE8616-5F38-47F0-A271-D35D9E8FEE35

Q34796086-1C1E4813-A395-4D4D-BEAC-1F0643BE6368

Q34796086-4EE714B4-399E-4675-B793-707B2E3575D8

Q34796086-6945B081-0281-4485-9E2D-4E61BB97CE32

Q34796086-70BF13DA-8E53-4A9A-AD65-12C630E4DC34

Q34796086-D6023E5E-665C-4FDE-93EC-29C94F4E040C

Q34796086-E717FCB7-DF1C-4A09-9241-1D97B656C07C

P2860

Q34796086-044F3E93-6310-421B-B571-0284F6EC3BF3

Q34796086-050E046E-483C-4409-8FF4-2EB0C5FFCBFA

Q34796086-0622C3BB-B105-4AAD-A28E-88A584BECE17

Q34796086-06866A30-5B2C-4D94-92A6-428E2C6EBE9A

Q34796086-0D11725B-BCB0-47A1-B760-A72EB2467987

Q34796086-11FFDE24-6AA0-4828-AFE6-390620D4AD20

Q34796086-13E2F9BE-E9B0-4EC6-8FDB-00FDA049980B

Q34796086-13FE5C47-A69F-4B4E-A483-51B2EFE948D7

Q34796086-2AFCB2D0-DFBD-4019-B8A1-0CB8D0792B9D

Q34796086-2B297393-1505-41E6-89D6-3A85D6C695F1

P2888

Q34796086-80C250AF-A13A-4C91-80E4-813B4718CBB6

P304

Q34796086-0D5E7237-151D-4629-995D-01A32C09ADCF

P31

Q34796086-D92B8FBF-04F9-4367-9845-2F85EF9DA238

P356

Q34796086-27DAFEA6-B59E-4A20-ACEF-56177B3F484B

P407

Q34796086-9BA3FB20-1F00-4D7C-A210-526F847994F6

P433

Q34796086-41031665-0E7B-4E3D-88CD-08434406D4E8

P478

Q34796086-504D2334-70CB-461C-9D9A-F0E112A01287

P577

Q34796086-3C8BD79F-A635-41A6-A7D8-DFD1FEA05235

P5875

Q34796086-AB415CDD-EB3E-4208-B17D-62AAD5AFFAB7

P6179

Q34796086-9C2CE8AA-8523-4B98-8137-A2EA1B5C8394

P698

Q34796086-C5946DCD-EE1D-4EA2-8170-2A9E6578B038

P932

Q34796086-5B4DED83-C9D7-469E-B6EC-688ADE895D72

P356

S12325-010-0103-9

P1433

Advances in Therapy

P1476

Mind-mapping for lung cancer: towards a personalized therapeutics approach

@en

P2093

A K Salama

http://www.w3.org/2001/XMLSchema#string

A N Husain

http://www.w3.org/2001/XMLSchema#string

C Demchuk

http://www.w3.org/2001/XMLSchema#string

M Surati

http://www.w3.org/2001/XMLSchema#string

N Mollberg

http://www.w3.org/2001/XMLSchema#string

R Fathi

http://www.w3.org/2001/XMLSchema#string

R Salgia

http://www.w3.org/2001/XMLSchema#string

T Hensing

http://www.w3.org/2001/XMLSchema#string

P2860

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.

Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.

P2888

s12325-010-0103-9

P304

173-194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-010-0103-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49851292

http://www.w3.org/2001/XMLSchema#string

P6179

1013140465

http://www.w3.org/2001/XMLSchema#string

P698

21337123

http://www.w3.org/2001/XMLSchema#string

P932

3077059

http://www.w3.org/2001/XMLSchema#string